Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Articles

The agency recommended approval of treatments for hepatitis C, cancer, multiple sclerosis, and arthritis.


EMA Recommends Approval for Eight New Drugs, One Biosimilar

A loan from the European Investment Bank will give BiondVax resources for Phase III trials and a manufacturing facility for its universal flu vaccine.


BiondVax Receives European Union Investment in Universal Flu Vaccine Development

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

The need for flexibility and higher quality are driving advances in parenteral manufacturing and fill/finish equipment. 

Looking at Trends in Parenteral Manufacturing

FDA Commissioner Scott Gottlieb announced the agency will hold a public meeting on drug competition as part of its Drug Competition Action Plan. 


FDA Announces Public Meeting on Generic Drugs

The European Commission approved Rixathon for use in all indications of its reference medicine, MabThera. 


Sandoz Scores European Approval for Biosimilar Rituximab

Aptar now manufactures its child-resistant pump, designed to meet US CPC requirements, at its facility in Congers, New York. 

Aptar Adds Nasal Pump Manufacturing Capacity

At an industry seminar hosted by Leistritz Extrusion, experts explained the use of extrusion equipment to mix polymeric excipients with APIs for solubility enhancement and for multifunctional and specialty dosage forms, including implants. 


Twin-Screw Extruders Serve the Pharma Industry

Caroline Hroncich was associate editor for Pharmaceutical Technology, Pharmaceutical Technology Europe, and BioPharm International from 2015 to 2017.

The landmark decision determined that biosimilar makers can notify manufacturers before receiving FDA approval. 


Supreme Court Rules in Amgen v. Sandoz

Takeda will build a new production facility at its existing Grange Castle site in Ireland.

Takeda Constructs High-Containment Facility in Ireland

Randi Hernandez was science editor at Pharmaceutical Technology from September 2014 to May 2017.

As cost pressures mount as a result of multiple biologics being developed for the same indication, manufacturers can harness process efficiencies to maintain the value of legacy products.
